Quantitative Systematic Strategies’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-22,105
Closed -$2.52M 625
2020
Q2
$2.52M Buy
22,105
+16,696
+309% +$1.77M 0.5% 36
2020
Q1
$434K Sell
5,409
-4,883
-47% -$506K 0.36% 101
2019
Q4
$1.1M Buy
10,292
+5,182
+101% +$540K 0.16% 199
2019
Q3
$547K Buy
5,110
+1,952
+62% +$200K 0.13% 216
2019
Q2
$322K Buy
+3,158
New +$303K 0.06% 320
2016
Q1
Sell
-4,363
Closed -$313K 507
2015
Q4
$313K Buy
+4,363
New +$293K 0.08% 346
2015
Q1
Sell
-35,148
Closed -$2.39M 433
2014
Q4
$2.39M Buy
+35,148
New +$2.22M 0.96% 16
2014
Q2
Sell
-6,429
Closed -$372K 272
2014
Q1
$372K Buy
+6,429
New +$345K 0.31% 152

Other funds holding DGX

Quantitative Systematic Strategies's DGX Position: Q3 2020 in Review

Quantitative Systematic Strategies sold out of Quest Diagnostics (DGX) in Q3 2020, closing a stake of 22,105 shares — an estimated $2.52M sold.

Quantitative Systematic Strategies first reported a position in DGX in Q1 2014 and held it in 8 quarters. The position peaked at $2.52M in Q2 2020. 758 funds tracked by Wall St. Rank hold DGX as of Q3 2020.

  • Quantitative Systematic Strategies reported no remaining Quest Diagnostics position as of Q3 2020 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 22,105 Quest Diagnostics shares in Q3 2020, an estimated $2.52M.
  • Quantitative Systematic Strategies first reported a position in Quest Diagnostics in Q1 2014 and held it in 8 quarters.
  • Quantitative Systematic Strategies's Quest Diagnostics position peaked at $2.52M in Q2 2020.
  • 758 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2020, filed 9 Nov 2020.